Multiple myeloma minimal residual disease analysis [Presence] in Bone marrow by NAA with non-probe detection

MM MRD anlyss Mar Ql NAA+n-prb

Definition

This test is to detect the minimal residual disease (MRD) or the small number of Multiple myeloma cancer cells that may remain in a patient's body after treatment and are not detectable using conventional diagnostic methods.

3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; BM; BON; Bone marrow; Dis; Diseases; DNA NUCLEIC ACID PROBE; DNA probe; Dz; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; MM MRD anlyss; Molecular pathology; MOLPATH; Mult; Multi; NAA+n-prb; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

9 further terms